Findings from Shanxi Medical University in Alzheimer Disease Reported (A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease)

Presse/Média: Research

Périodenov. 8 2022

Couverture média

1

Couverture média

  • TitreFindings from Shanxi Medical University in Alzheimer Disease Reported (A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease)
    Nom du médiaPain & Central Nervous System Daily News
    Pays/TerritoireUnited States
    Date11/8/22
    PersonnesJun Wang